Fundz

Nervonik raised $13 million in a Series A financing round led by U.S. Venture Partners to advance its opioid-free peripheral nerve stimulation system for chronic pain relief.

PRIVATEMar 04, 2025

Amount Raised

$13 Million

Round Type

Series A

Los AngelesBiotechnologyHealth CareMedicalMedical Device

Investors

Correlation VenturesFoothill VenturesU.S. Venture Partners

Description

Nervonik, Inc. has successfully closed a $13 million Series A funding round to enhance its clinical studies and prepare for commercialization of its innovative pain relief technology. The round was led by U.S. Venture Partners, with participation from several other investors.

Quick answer

Nervonik raised $13 Million in a Series A round, dated March 4, 2025. Investors: Correlation Ventures, Foothill Ventures and U.S. Venture Partners. Nervonik is based in Los Angeles, California, United States.

How much did Nervonik raise?
Nervonik raised $13 Million in a Series A round on March 4, 2025.
Who invested in Nervonik?
Correlation Ventures, Foothill Ventures and U.S. Venture Partners are named as investors in this round.
What does Nervonik do?
Nervonik is a medical device company developing cutting-edge peripheral nerve stimulation (PNS) solutions to treat chronic pain.
Where is Nervonik based and how big is it?
Nervonik is based in Los Angeles, California, United States. Fundz records about 4 employees.
Who are the decision-makers at Nervonik?
Fundz holds 2 contacts at Nervonik, including the Sr. Director of Engineering and Supply Chain. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who to call at Nervonik, and when

A new round usually means Nervonik is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Nervonik raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Nervonik, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Nervonik. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Nervonik

Location

Los Angeles, California, United States

About

Nervonik is a medical device company developing cutting-edge peripheral nerve stimulation (PNS) solutions to treat chronic pain. Leveraging advanced, proprietary, wireless power, and closed-loop sensing technologies, Nervonik is committed to providing minimally invasive, effective, and patient-centric treatment options. Nervonik is focused on advancing clinical research and achieving regulatory milestones to bring its innovative therapies to market.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Nervonik raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsRanjan N., Sr. Director of Engineering and Supply… hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Nervonik's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Nervonik raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.